{"pmid":32331984,"title":"Surgical management of bone and soft tissue sarcomas and skeletal metastases during the COVID-19 pandemic.","text":["Surgical management of bone and soft tissue sarcomas and skeletal metastases during the COVID-19 pandemic.","Eur J Surg Oncol","Cardoso, Pedro","Rodrigues-Pinto, Ricardo","32331984"],"journal":"Eur J Surg Oncol","authors":["Cardoso, Pedro","Rodrigues-Pinto, Ricardo"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32331984","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.ejso.2020.04.027","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1665071049770795008,"score":8.518259,"similar":[{"pmid":32292693,"pmcid":"PMC7152868","title":"Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper.","text":["Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper.","The current health crisis caused by COVID-19 is a challenge for oncology treatment, especially when it comes to radiotherapy. Cancer patients are already known to be very fragile and COVID-19 brings about the risk of severe respiratory complications. In order to treat patients safely while protecting medical teams, the entire health care system must optimize the way it approaches prevention and treatment at a time when social distancing is key to stemming this pandemic. All indications and treatment modalities must be re-discussed. This is particularly the case for radiotherapy of bone metastases for which it is possible to reduce the number of sessions, the frequency of transport and the complexity of treatments. These changes will have to be discussed according to the organization of each radiotherapy department and the health situation, while medical teams must remain vigilant about the risks of complications of bone metastases, particularly spinal metastases. In this short piece, the members of the GEMO (the European Study Group of Bone Metastases) offer a number of recommendations to achieve the above objectives, both in general and in relation to five of the most common situations on radiation therapy for bone metastases.","J Bone Oncol","Thureau, Sebastien","Faivre, Jean Christophe","Assaker, Richard","Biver, Emmanuel","Confavreux, Cyrille B","Debiais, Francoise","Duterque-Coquillaud, Martine","Giammarile, Fransesco","Heymann, Dominique","Lecouvet, Frederic E","Morardet, Laetitia","Paycha, Frederic","Body, Jean-Jacques","Vieillard, Marie-Helene","32292693"],"abstract":["The current health crisis caused by COVID-19 is a challenge for oncology treatment, especially when it comes to radiotherapy. Cancer patients are already known to be very fragile and COVID-19 brings about the risk of severe respiratory complications. In order to treat patients safely while protecting medical teams, the entire health care system must optimize the way it approaches prevention and treatment at a time when social distancing is key to stemming this pandemic. All indications and treatment modalities must be re-discussed. This is particularly the case for radiotherapy of bone metastases for which it is possible to reduce the number of sessions, the frequency of transport and the complexity of treatments. These changes will have to be discussed according to the organization of each radiotherapy department and the health situation, while medical teams must remain vigilant about the risks of complications of bone metastases, particularly spinal metastases. In this short piece, the members of the GEMO (the European Study Group of Bone Metastases) offer a number of recommendations to achieve the above objectives, both in general and in relation to five of the most common situations on radiation therapy for bone metastases."],"journal":"J Bone Oncol","authors":["Thureau, Sebastien","Faivre, Jean Christophe","Assaker, Richard","Biver, Emmanuel","Confavreux, Cyrille B","Debiais, Francoise","Duterque-Coquillaud, Martine","Giammarile, Fransesco","Heymann, Dominique","Lecouvet, Frederic E","Morardet, Laetitia","Paycha, Frederic","Body, Jean-Jacques","Vieillard, Marie-Helene"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292693","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jbo.2020.100291","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664636192766820353,"score":104.495605},{"pmid":32278878,"pmcid":"PMC7144615","title":"French Sarcoma Group proposals for management of sarcoma patients during COVID-19 outbreak.","text":["French Sarcoma Group proposals for management of sarcoma patients during COVID-19 outbreak.","Ann Oncol","Penel, N","Bonvalot, S","Minard, V","Orbach, D","Gouin, F","Corradini, N","Brahmi, M","Marec-Berard, P","Briand, S","Gaspar, N","Llacer, C","Carrere, S","Dufresne, A","Le Cesne, A","Blay, J Y","32278878"],"journal":"Ann Oncol","authors":["Penel, N","Bonvalot, S","Minard, V","Orbach, D","Gouin, F","Corradini, N","Brahmi, M","Marec-Berard, P","Briand, S","Gaspar, N","Llacer, C","Carrere, S","Dufresne, A","Le Cesne, A","Blay, J Y"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32278878","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.annonc.2020.03.308","keywords":["covid-19","management","sarcoma"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664636873219244032,"score":81.138824},{"pmid":32265035,"pmcid":"PMC7118687","title":"[French Sarcoma Group proposals for management of sarcoma patients during COVID-19 outbreak].","text":["[French Sarcoma Group proposals for management of sarcoma patients during COVID-19 outbreak].","Bull Cancer","Penel, Nicolas","Bonvalot, Sylvie","Minard, Veronique","Orbach, Daniel","Gouin, Francois","Corradini, Nadege","Brahmi, Mehdi","Marec-Berard, Perrine","Briand, Sylvain","Gaspar, Nathalie","Llacer, Carmen","Carrere, Sebastien","Dufresne, Armelle","Le Cesne, Axel","Blay, Jean-Yves","32265035"],"journal":"Bull Cancer","authors":["Penel, Nicolas","Bonvalot, Sylvie","Minard, Veronique","Orbach, Daniel","Gouin, Francois","Corradini, Nadege","Brahmi, Mehdi","Marec-Berard, Perrine","Briand, Sylvain","Gaspar, Nathalie","Llacer, Carmen","Carrere, Sebastien","Dufresne, Armelle","Le Cesne, Axel","Blay, Jean-Yves"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32265035","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.bulcan.2020.03.009","keywords":["covid-19","management","prise en charge","sarcoma","sarcome"],"source":"PubMed","weight":0,"_version_":1664637636005855234,"score":76.17459},{"pmid":32314871,"title":"Targeting the Adipose Tissue in COVID-19.","text":["Targeting the Adipose Tissue in COVID-19.","The WHO considers non-communicable diseases (NCDs), such as obesity, a major risk factor for becoming seriously ill with 2019 novel coronavirus (COVID-19) (1). A study by the UK Intensive Care National Audit and Research Centre indicates that two thirds of people who developed serious or fatal COVID-19-related complications were overweight or obese (2). The report includes data from all COVID-19 admissions in intensive care units in the UK until midnight, March 19, 2020. The study shows that almost 72 % of those in critical care units are either overweight or with obesity suggesting the impact of obesity in seriously ill COVID-19 patients.","Obesity (Silver Spring)","Malavazos, Alexis Elias","Corsi Romanelli, Massimiliano Marco","Bandera, Francesco","Iacobellis, Gianluca","32314871"],"abstract":["The WHO considers non-communicable diseases (NCDs), such as obesity, a major risk factor for becoming seriously ill with 2019 novel coronavirus (COVID-19) (1). A study by the UK Intensive Care National Audit and Research Centre indicates that two thirds of people who developed serious or fatal COVID-19-related complications were overweight or obese (2). The report includes data from all COVID-19 admissions in intensive care units in the UK until midnight, March 19, 2020. The study shows that almost 72 % of those in critical care units are either overweight or with obesity suggesting the impact of obesity in seriously ill COVID-19 patients."],"journal":"Obesity (Silver Spring)","authors":["Malavazos, Alexis Elias","Corsi Romanelli, Massimiliano Marco","Bandera, Francesco","Iacobellis, Gianluca"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314871","week":"202017|Apr 20 - Apr 26","doi":"10.1002/oby.22844","keywords":["ace2","covid-19","adipose tissue: dpp4"],"source":"PubMed","topics":["Treatment"],"weight":1,"locations":["GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"_version_":1664714520065474561,"score":41.55581},{"pmid":32307107,"title":"[French Society for Surgical Oncology (SFCO) guidelines for the management of surgical oncology in the pandemic context of COVID 19].","text":["[French Society for Surgical Oncology (SFCO) guidelines for the management of surgical oncology in the pandemic context of COVID 19].","Bull Cancer","Classe, Jean-Marc","Dolivet, Gilles","Evrard, Serge","Ferron, Gwenael","Lecuru, Fabrice","Leufflen, Lea","Rivoire, Michel","Sgarbura, Olivia","32307107"],"journal":"Bull Cancer","authors":["Classe, Jean-Marc","Dolivet, Gilles","Evrard, Serge","Ferron, Gwenael","Lecuru, Fabrice","Leufflen, Lea","Rivoire, Michel","Sgarbura, Olivia"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307107","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.bulcan.2020.03.010","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["French"],"countries":["France"],"countries_codes":["FRA|France"],"_version_":1664632501489893376,"score":40.971268}]}